Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19
Status:
Recruiting
Trial end date:
2021-07-31
Target enrollment:
Participant gender:
Summary
This Clinical Trial evaluates nasal administration of Dexamethasone as an adjuvant treatment
strategy for non-critically ill hospitalized participants with SARS CoV-2 infection.